ACTR-31. THE USE OF TTFIELDS FOR NEWLY DIAGNOSED GBM PATIENTS IN GERMANY IN ROUTINE CLINICAL CARE (TIGER: TTFIELDS IN GERMANY IN ROUTINE CLINICAL CARE)

OBJECTIVE: Survival for the most common brain tumor, glioblastoma (GBM), has not improved since 2005, despite numerous phase 3 trials. The phase 3 EF-14 trial demonstrated significantly improved overall, progression-free and long-term survival in newly diagnosed GBM (ndGBM) patients by addition of T...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Neuro Oncol
Asıl Yazarlar: Bähr, Oliver, Tabatabai, Ghazaleh, Fietkau, Rainer, Goldbrunner, Roland, Glas, Martin
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2019
Konular:
Adult Clinical Trials - Non-Immunologic
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6847596/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.074
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller